Lack of intrinsic polarity in the ligand-binding ability of keratinocyte β1 integrins

Experimental Dermatology

Volumn 7, Issue 6, 1998, Pages 350-361

  Bishop, L A ^a   Kee, W J ^a   Zhu, A J ^a   Watt, F M ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Epidermis; Extracellular matrix; Polarity

Indexed keywords

CD8 ANTIGEN; EPITOPE; INTEGRIN;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; LIGAND BINDING;

EID: 0031792111     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1998.tb00335.x     Document Type: Article

References (63)

1. Watt F M, Hertle M D. Keratinocyte integrins. In: Leigh I M, Lane E B, Watt F M, eds. The Keratinocyte Hand-book. Cambridge: Cambridge University Press, 1994: 153-164.
2. Borradori L, Sonnenberg A. Hemidesmosomes: roles in adhesion, signaling and human diseases. Curr Opin Cell Biol 1996: 8: 647-656.
3. Guo M, Toda K-I, Grinnell F. Activation of human keratinocyte migration on type I collagen and fibronectin. J Cell Sci 1990: 96: 197-205.
4. 1 epiligrin receptor. J Invest Dermatol 1992: 98: 764-770.
5. 1 integrin loss from the cell surface. Cell 1990: 63: 425-435.
6. 1 integrin in keratinocytes is reversible but commitment to terminal differentiation is not. J Cell Sci 1993: 106: 1131-1138.
7. Jensen P J, Wheelock M J The relationships among adhesion, stratification and differentiation in keratinocytes. Cell Death Differ 1996: 3: 357-371.
8. Adams J C, Watt F M. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 1989: 340: 307-309
9. Watt F M, Kubler M-D, Hotchin N A, Nicholson L J, Adams J C. Regulation of keratinocyte terminal differentiation by integrin-extracelluiar matrix interactions. J Cell Sci 1993: 106: 175-182.
10. Jones P H, Watt F M. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 1993: 73: 713-724.
11. Jones P H, Harper S, Watt F M. Stem cell patterning and fate in human epidermis. Cell 1995: 80: 83-93.
12. Hertle M D, Kubler M-D, Leigh I M, Watt F M. Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J Clin Invest 1992: 89: 1892-1901.
13. Carroll J M, Romero M R, Watt F M. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 1995: 83: 957-968.
14. Wolf G T, Carey T E. Tumor antigen phenotype, biological staging, and prognosis in head and neck squamous carcinoma. J Natl Cancer Inst Monogr 1992: 13: 67-74.
15. Jones J, Sugiyama M, Watt F M, Speight P M. Integrin expression in normal, hyperplastic. dysplastic, and malignant oral epithelium. J Pathol 1993: 169: 235-243.
16. 1, integrin expression during keratinocyte terminal differentiation. J Biol Chem 1992: 267: 14852-14858.
17. 1 integrin levels during keratinocyte terminal differentiation. J Cell Biol 1995: 128: 1209-1219.
18. 1 intesrins in chronic inflammatory diseases. Eur J Immunol 1995: 25: 1720-1728.
19. 1 integrin epitope induced by soluble ligand and manganese, but inhibited by calcium. J Biol Chem 1995: 270: 25570-25577.
20. 1 subunit. FEBS Lett 1995: 363: 118-122.
21. LaFlamme S E, Akiyama S K, Yamada K M. Regulation of fibronectin receptor distribution. J Cell Biol 1992: 117: 437-447.
22. 1 integrins in keratinocyte cell-cell junctions are not in the ligand-occupied conformation. J Invest Dermatol 1997: 108: 876-880.
23. Rheinwald J G. Methods for clonal growth and serial cultivation of normal human epidermal keratinocytes and mesothelial cells. In: Baserga R, ed. Cell Growth and Division. A Practical Approach. Oxford: IRL Press, 1989: 81-94.
24. Watt F M. Cultivation of human epidermal keratinocytes with a 3T3 feeder layer. In: Cehs J E. ed. Cell Biology: A Laboratory Handbook. London: Academic Press, 1994: vol. 1, 83-89.
25. Hodivala K J, Watt F M. Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J Cell Biol 1994: 124: 589-600.
26. Zhu A J, Watt F M. Expression of a dominant negative cadherin mutant inhibits proliferation and stimulates terminal differentiation of human epidermal keratinocytes. J Cell Sci 1996: 109: 3013-3023.
27. Pruniéras M, Régnier M, Woodley D. Methods for cultivation of keratinocytes with an air-liquid interface. J Invest Dermatol 1983: 81: 28s-33s.
28. Rikimaru K, Molès J-R Watt F M. Correlation between hyperprohferation and suprabasal integrin expression in human epidermis reconstituted in culture. Exp Dermatol 1997: 6: 214-221.
29. 2 "activation" epitopes during T-cell responses in secondary lymphoid tissue. Eur J Immunol 1993: 23: 2751-2757.
30. Akiyama S K, Yamada S S, Chen W-T, Yamada K M. Analysis of fibronectin receptor function with monoclonal antibodies: role in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 1989: 109: 863-875.
31. Dittel B N, McCarthy J B, Wayner E A, LeBien T W. Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood 1993: 81: 2272-2282.
32. 1 integrin (CD29) stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components. J Cell Biol 1992: 116: 499-509.
33. 5 by human epidermal keratinocytes and non-differentiating keratinocytes. J Cell Biol 1991: 115: 829-841.
34. 1 integrins in human epidermal keratinocytes. Cell Adhes Commun 1996: 4: 297-305.
35. DeStrooper B, Saison M, Jaspers M et al. Monoclonal DH12 reacts with cell surface and a precursor form of the β subunit of the human fibronectin receptor. Cell Biol Int Rep 1988: 12: 9-16.
36. Beverley P C. The application of monoclonal antibodies to the typing and isolation of lymphoreticular cells. Proc Roy Soc Edinburgh 1982: 81B: 224-232.
37. Hudson D L, Weiland K L, Dooley T P, Simon M, Watt F M. Characterisation of eight monoclonal antibodies to involucrin. Hybridoma 1992: 11: 367-379.
38. Humphries M J. Integrin activation: the link between liaand binding and signal transduction. Curr Opin Cell Biol 1996: 8: 632-640.
39. 3 subunit: studies with human keratinocytes. Cell Adhes Commun 1995: 3: 243-255.
40. 4. Nature 1970: 227: 680-685.
41. Nilsson T, Jackson M R, Peterson P A. Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 1989: 58: 707-718.
42. Morgenstern J P, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990: 18: 3587-3596.
43. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 1988: 167: 400-406.
44. Hertle M D, Jones P H, Groves R W, Hudson D L, Watt F M. Integrin expression by human epidermal keratinocytes can be modulated by interferon-γ, transforming growth factor-β, tumour necrosis factor-α and culture on a dermal equivalent. J Invest Dermatol 1995: 104: 260-265.
45. Hynes R O. Expression of fibronectins by cells in culture. In: Fibronectins 1990. pp. 49-83.
46. Watt F M, Mattey D L, Garrod D R. Calcium-induced reorganization of desmosomal components in cultured human keratinocytes. J Cell Biol 1984: 99: 2211-2215.
47. Akiyama S K, Larjava H, Yamada K M. Differences in the biosynthesis and localization of the fibronectin receptor in normal and transformed cultured human cells. Cancer Res 1990: 50: 1601-1607.
48. 1-integrin but lack an intracellular pool of mature subunit. Eur J Biochem 1991: 199: 25-33.
49. Miyamoto S, Akiyama S K, Yamada K. M. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 1995: 267: 883-885.
50. Alitalo K, Kuismanen E, Myllylä R. Kiistala U, Askoseljavaara S, Vaheri A. Extracellular matrix proteins of human epidermal keratinocytes and feeder 3T3 cells. J Cell Biol 1982: 94: 497-505.
51. 1 integrin during terminal differentiation of human keratinocytes. J Cell Sci 1991: 98: 225-232.
52. Hertle M D, Adams J C, Watt F M. Integrin expression during human epidermal development in vivo and in vitro. Development 1991: 112: 193-206.
53. 1 integrins at cell-cell contacts and does not involve changes in the levels or phosphorylation of catenins. Cell Adhes Comm. 1998 in press.
54. O'Toole T E, Loftus J C, Plow E F, Glass A A, Harper J R, Ginsberg M H. Efficient surface expression of platelet GPIIb-IIIa requires both subunits. Blood 1989: 74: 14-18.
55. 1 subunit by epitope mappina. J Cell Biol 1993: 122: 1361-1371.
56. 1 subunits and concomitant loss of fibronectin binding activity. J Biol Chem 1994: 269: 12325-12331.
57. 1 integrin-dependent cell adhesion is regulated by a low affinity recep-tor pool that is conformationally responsive to ligand. J Biol Chem 1995: 270: 28740-28750.
58. 1 cytoplasmic domain. J Biol Chem 1996: 271: 16580-16585.
59. Faull R J, Kovach N L, Harlan J M, Ginsberg M H. Stimulation of integrin-mediated adhesion of T lymphocytes and monocyies: two mechanisms with divergent biological consequences. J Exp Med 1994: 179: 1307-1316.
60. Diamond M S, Springer T A. The dynamic regulation of integrin adhesiveness. Curr Biol 1994: 4: 506-517.
61. Faull R J, Ginsberg M H. Dynamic regulation of integrins. Stem Cells 1995: 13: 38-46.
62. Lub M, van Kooyk Y, Figdor C G. Ins and outs of LFA-1. Immunol Today 1995: 16: 479-483.
63. Stewart M, Hogg N. Regulation of leukocyte integrin function: affinity vs. avidity. J Cell Biochem 1996: 61: 554-561.